Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

ProteinSimple  (Stock symbol: PRTN ) Acquired by Bio-Techne (2014 $ 300,000,000 )

3040 Oakmead Village Drive
Santa Clara, CA 94051
USA
(408) 510-5500
Website Company Summary Management Team
Board

Outside board: (May no longer be on the board) Joseph D. Keegan (ForteBio Former CEO) James N. Woody (Latterell Venture Partners) A. Blaine Bowman (Dionex Former President/CEO) Chris van Ingen (Agilent Technologies Division President) David L. Barker (Illumina Former Chief Scientific Officer) Jack B. Nielsen (Novo Ventures Partner)
Former outside board: Roy Whitfield (Incyte Former CEO) James C. Blair (Domain Associates) Lawrence A. Lasky (Latterell Venture Partners) Jim Schlater (ProteinSimple Chairman) Lawrence Jay Korn (PDL BioPharma Former CEO) James McCoy (Maxtor President & Chairman) Julie Eskay-Eagle (The Wellcome Trust Co-Head of Health Care and Venture Capital Investments)
Company

Business description: ProteinSimple has the goal to simply to help researchers gain a better understanding of proteins and their role in disease. We develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins. We believe that traditional protein analysis tools can be overly complex or inadequate, and our goal is to make protein analysis simpler, more quantitative and affordable. Our comprehensive portfolio of tools includes Simple Western systems that provide fresh insight into protein expression and Biologics systems that probe the structure and purity of protein-based therapeutics. We have over 180 employees, 14,000 systems installed around the world and our headquarters is in Santa Clara, California.
Capital

Rounds: 6
Recent Fundings: May 2011   Dec 2009
Capital raised: 42.0M
Last Round: 13.0M
Ownership: Acquired by Bio-Techne (2014 $ 300,000,000 ) Ipo Filing
Stock Symbol: PRTN
VCs include: Domain AssociatesEssex Woodlands Health VenturesRBC Capital Partners;  Posco BioVentures;  The Vertical GroupLatterell Venture Partners;  Lansing Brown Investments;  Wellcome Trust
Corporate investors: Novo Nordisk;  Mitsui Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Feb 2017
Sector: Biotech
Year Founded: 2004
Headcount: 151-200 as of Jul 2011
Rounds: 6
Recent Fundings: May 2011   Dec 2009
Capital Raised: 42.0M
Last Round: 13.0M
Ownership: Acquired by Bio-Techne (2014 $ 300,000,000 ) Ipo Filing
Stock Symbol: PRTN